The Investor
25 Oct 2025, 08:21
HCA Healthcare Reports 9.6% Revenue Growth and Record $6.96 EPS in Q3 2025
HCA Healthcare (NYSE: HCA) reported strong third-quarter 2025 results, with revenue rising 9.6% to $19.16 billion and net income increasing 29.4% to $1.64 billion, driven by higher patient volumes and improved pricing. Diluted earnings per share surged 42.6% to $6.96, while adjusted EBITDA climbed 18.5% to $3.87 billion.
Same-facility admissions grew 2.1%, and equivalent admissions rose 2.4%, reflecting steady patient demand. Emergency room visits were up 1.3%, inpatient surgeries rose 1.4%, and outpatient surgeries increased 1.1%. Same-facility revenue per equivalent admission advanced 6.6%, supported by pricing strength and service mix improvements.
Operating cash flow reached $4.42 billion, up from $3.52 billion a year earlier. HCA ended the quarter with $997 million in cash, $44.51 billion in total debt, and $59.75 billion in total assets. The company also invested $1.29 billion in capital expenditures and repurchased 6.51 million shares for $2.5 billion, with $3.26 billion remaining under its buyback authorization.
For the first nine months of 2025, HCA generated $56.09 billion in revenue and $4.91 billion in net income ($20.23 per share), up from $4.32 billion in the same period of 2024. The company declared a quarterly dividend of $0.72 per share, payable on December 29, 2025, to shareholders of record as of December 15, 2025.
HCA Healthcare (NYSE: HCA) reported strong third-quarter 2025 results, with revenue rising 9.6% to $19.16 billion and net income increasing 29.4% to $1.64 billion, driven by higher patient volumes and improved pricing. Diluted earnings per share surged 42.6% to $6.96, while adjusted EBITDA climbed 18.5% to $3.87 billion.
Same-facility admissions grew 2.1%, and equivalent admissions rose 2.4%, reflecting steady patient demand. Emergency room visits were up 1.3%, inpatient surgeries rose 1.4%, and outpatient surgeries increased 1.1%. Same-facility revenue per equivalent admission advanced 6.6%, supported by pricing strength and service mix improvements.
Operating cash flow reached $4.42 billion, up from $3.52 billion a year earlier. HCA ended the quarter with $997 million in cash, $44.51 billion in total debt, and $59.75 billion in total assets. The company also invested $1.29 billion in capital expenditures and repurchased 6.51 million shares for $2.5 billion, with $3.26 billion remaining under its buyback authorization.
For the first nine months of 2025, HCA generated $56.09 billion in revenue and $4.91 billion in net income ($20.23 per share), up from $4.32 billion in the same period of 2024. The company declared a quarterly dividend of $0.72 per share, payable on December 29, 2025, to shareholders of record as of December 15, 2025.